If you liked this article you might like

Wall Street Still Embraces Trump's Agenda, but Can He Deliver?
Buy 'Trump Stocks' on Any Market-Induced Weakness: Cramer's 'Mad Money' Recap (Friday 1/20/17)
Jim Cramer on Bristol-Myers' Opdivo/Yervoy Combo: 'That Story Was Taken Away From Us'
Stocks Rising as Donald Trump Inherits the White House